
|Articles|June 15, 2004
Short-term results of custom ablation stable over 2 years
Higher-order aberrations decreased in most patients, with the change from baseline reaching up to 50%.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
2
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
3
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
4
Ocular Therapeutix randomizes first patient in HELIOS-3
5

















































.png)


